Fundraising Fox

Cadenza Bio

Yukon, US · Founded 2022 · Delaware corporation · 3 known investors

cadenza.bio ↗

Cadenza Bio develops small-molecule drugs for oral administration to treat demyelinating and inflammatory diseases. The company focuses on halting disease progression and promoting tissue repair in patients with debilitating conditions.

BiotechFemTechMedical Devicesin /cadenza-bio

Founders & leadership

CC
Carol Curtis, PhDChief Executive Officer, Founder
EH
Elaine Hamm, PhDChief Operating Officer, Founder
JKJohn Katzenellenbogen, PhD
John Katzenellenbogen, PhDScientific Founder
STSeema Tiwari-Woodruff, PhD
Seema Tiwari-Woodruff, PhDScientific Founder
EH
Elaine HammExecutive Officer, Director
TD
Tom DenisonDirector
CC
Carol CurtisExecutive Officer, Director

Investors · 3

Cortado VenturesOklahoma City
Illinois VenturesChampaign
Plains VenturesOklahoma City · $250K – $1M

Reported raises · per SEC filings

Form D private placements
▶$2.4MraisedAug 2025 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Elaine HammExecutive Officer, Director
  • Tom DenisonDirector
  • Carol CurtisExecutive Officer, Director
Offering amount
$2.4M
Amount sold
$2.4M
First sale
Dec 2023
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news